Wilson's disease overview: Difference between revisions

Jump to navigation Jump to search
Line 44: Line 44:


===Physical Examination===
===Physical Examination===
Patients with Wilson's disease usually appear tired. Physical examination of patients with Wilson's disease is usually remarkable for jaundice and easy bruising in the skin. Physical examination also is remarkable for Kayser Fleischer ring in the eyes as a result of the copper accumulation in the cornea. Common physical examination findings in the abdomen include abdominal tenderness , ascites, and spider angiomata. Common neurolopsychiatric signs include seizures, parkinsonism like signs, depression, and anxiety.


===Laboratory Findings===
===Laboratory Findings===

Revision as of 16:51, 26 December 2017

https://https://www.youtube.com/watch?v=Cr8R_bnKAtk%7C350}}


Wilson's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Wilson's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Wilson's disease overview On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Wilson's disease overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wilson's disease overview

CDC on Wilson's disease overview

Wilson's disease overview in the news

Blogs on Wilson's disease overview

Directions to Hospitals Treating Wilson's disease

Risk calculators and risk factors for Wilson's disease overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

Historical Perspective

Wilson's disease was first described by Dr. Samuel Alexander Kinnier Wilson where he described the pathological changes in the brain and liver in 1912. Many research studies revealed the correlation between ATP7B gene mutation and Wilson's disease. The first effective oral chelator was discovered by Dr. Walshe in 1956.

Classification

Wilson's disease is classified based on the symptomatic presentation into hepatic and neurologic Wilson's disease.

Pathophysiology

Causes

Wilson's disease is caused by ATP7B gene mutation and impairement of copper transportation.

Differentiating Wilson's disease from Other Diseases

Wilson's disease must be differentiated from other diseases that cause jaundice like hemochromatosis, viral hepatitis, alcoholic hepatitis, drug induced hepatitis, and autoimmune hepatitis.

Epidemiology and Demographics

The prevalence of Wilson's disease is estimated to be 3 cases per 100,000 individuals worldwide. Wilson's disease affects individuals between 5 to 35 years old.

Risk Factors

Commpn risk factors of Wilson's disease include newborns of disease-carrier parents. Less common risk factors inlcude excess non-vegetarian diet.

Screening

There is insufficient evidence to recommend routine screening for Wilson's disease.

Natural History, Complications, and Prognosis

If left untreated, Wilson's disease will lead to death as the copper accumulation in the liver and brain will lead to cirrhosis and severe dystonia respectively. Common complications of Wilson's disease include hepatocellular carcinoma, renal failure, and persistent neurological manifestations. Prognosis of Wilson's disease is usually good in case of early detection and proper treatment.

Diagnosis

Diagnostic Criteria

History and Symptoms

Patients with Wilson's disease may remain asymptomatic until the copper deposits in the liver and brain mainly. Common hepatic symptoms include abdominal distension, abdominal pain, fatigue, bleeding tendency, and esophageal varices. Common neuropsychiatric symptoms include tremors, ataxia, dysarthria, and impulsiveness. Less common symptoms of wilson's disease include urolithiasis and hematuria.

Physical Examination

Patients with Wilson's disease usually appear tired. Physical examination of patients with Wilson's disease is usually remarkable for jaundice and easy bruising in the skin. Physical examination also is remarkable for Kayser Fleischer ring in the eyes as a result of the copper accumulation in the cornea. Common physical examination findings in the abdomen include abdominal tenderness , ascites, and spider angiomata. Common neurolopsychiatric signs include seizures, parkinsonism like signs, depression, and anxiety.

Laboratory Findings

Electrocardiogram

There are no EKG findings associated with Wilson's disease. However, if the heart is affected by Wilson's disease, EKG should be performed to exclude any ongoing arrhythmias.

X-ray

There are no x-ray findings associated with Wilson's disease.

Ultrasound

CT scan

CT scan can be used in detecting abnormalities in the brain but MRI is more sensetive in diagnosing Wilm's tumor associated with neurological manifestations.

MRI

There are no specific MRI findings associated with Wilson's disease especially in cases who present with only hepatic manifestations. However, it may show abnormalities in the basal ganglia in the patients who presented with neuropsychiatric manifestations.

Other Imaging Findings

There are no other imaging findings associated with Wilson's disease.

Other Diagnostic Studies

Liver biopsy is performed in suspected cases of Wilson's disease as it may show many histopathological features. Liver biopsy may show mild steatosis, hepatocellular necrosis, macronodular cirrhosis, and fulminant liver failure features as parenchymal collapse. Genetic testing is also recommended in Wilson's disease to obtain the family history of the disease and for early detection.

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

References


Template:WikiDoc Sources

References

Template:WH Template:WS